Showing 1-8 of 8 articles
Coronary interventions
Validation of the updated logistic clinical SYNTAX score for all-cause mortality in the GLOBAL LEADERS trial August 9, 2019 | 10.4244/EIJ-D-19-00184
Coronary interventions
BuMA Supreme biodegradable polymer sirolimus-eluting stent versus a durable polymer zotarolimus-eluting coronary stent: three-year clinical outcomes of the PIONEER trial July 30, 2019 | 10.4244/EIJ-D-19-00566
Coronary interventions
A prospective multicentre randomised all-comers trial to assess the safety and effectiveness of the thin-strut sirolimus-eluting coronary stent SUPRAFLEX: rationale and design of the Thin Strut Sirolimus-eluting Stent in All Comers Population vs Everolimus-eluting Stent (TALENT) trial July 19, 2019 | 10.4244/EIJ-D-18-00499
Coronary interventions
Interventional cardiology 2018: the year in review April 5, 2019 | 10.4244/EIJ-D-19-00040
Coronary interventions
Patient-oriented composite endpoints and net adverse clinical events with ticagrelor monotherapy following percutaneous coronary intervention: Insights from the randomized GLOBAL LEADERS trial March 17, 2019 | 10.4244/EIJ-D-19-00202
Coronary interventions
Two-year follow-up of the DESSOLVE III trial: bioabsorbable polymer sirolimus-eluting stent vs. durable polymer everolimus-eluting stent. February 5, 2019 | 10.4244/EIJ-D-18-00944
Coronary interventions
A randomised comparison of healing response between the BuMA Supreme stent and the XIENCE stent at one-month and two-month follow-up: PIONEER-II OCT randomised controlled trial December 20, 2018 | 10.4244/EIJ-D-18-00461